Expert Interview
Another Look: Discussing Praxis’ Essential1 & Essential3 Programs of Ulixacaltamide (PRAX-944) and the Topline Results in Essential Tremor
Ticker(s): PRAXInstitution: University of Kansas Medical Center
- Professor of Neurology & Director of the Parkinson's Disease and Movement Disorder Center at the University of Kansas Medical Center.
- Currently treats 50+ patients with essential tremor and 200 patients with PDP
- Published more than 250 peer-reviewed articles, chapters and abstracts in leading neurology and movement disorder journals. Conducted more than 75 clinical trials related to Parkinson's disease and other movement disorders.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
